ASX - Delayed Quote AUD

Imricor Medical Systems, Inc. (IMR.AX)

Compare
1.3000
+0.0800
+(6.56%)
At close: 4:10:18 PM GMT+11
Loading Chart for IMR.AX
DELL
  • Previous Close 1.2200
  • Open 1.2450
  • Bid 1.2750 x --
  • Ask 1.3000 x --
  • Day's Range 1.2150 - 1.3000
  • 52 Week Range 0.4100 - 1.5800
  • Volume 108,388
  • Avg. Volume 267,225
  • Market Cap (intraday) 351.229M
  • Beta (5Y Monthly) 0.25
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1800
  • Earnings Date Jan 29, 2025 - Feb 3, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 1.57

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.

www.imricor.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: IMR.AX

View More

Performance Overview: IMR.AX

Trailing total returns as of 1/16/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

IMR.AX
4.41%
MSCI WORLD
0.67%

1-Year Return

IMR.AX
140.74%
MSCI WORLD
0.00%

3-Year Return

IMR.AX
21.50%
MSCI WORLD
17.99%

5-Year Return

IMR.AX
11.11%
MSCI WORLD
56.51%

Compare To: IMR.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IMR.AX

View More

Valuation Measures

As of 1/15/2025
  • Market Cap

    329.61M

  • Enterprise Value

    345.56M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    175.78

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    278.40

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -124.67%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    824.32k

  • Net Income Avi to Common (ttm)

    -20.26M

  • Diluted EPS (ttm)

    -0.1800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.5M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -8.42M

Research Analysis: IMR.AX

View More

People Also Watch